Patient · Educator · Architect of a System

The person who built Israel's medical cannabis patient education system. From Patient #7.

In 2004, Gil Luxenbourg became the seventh person in Israel ever granted a Ministry of Health medical cannabis licence — and the first to receive one without a court order. What he found next was a medicine handed to patients with no instructions. The protocols, the patient education, the clinical onboarding system used by Israel's largest licensed operators — he built them.

Gil Luxenbourg

A crisis, a four-year fight, and a decision that changed an industry.

In 1999, Gil was a soldier in the Israeli military. Crohn's disease took 37 kilograms from his body in three months. Conventional medicine had run out of options. He weighed less than his gear. The doctors were out of ideas.

Medical cannabis stopped the decline. It was not yet a regulated medicine in Israel. There was no Ministry of Health programme, no licensed supply, no protocol — just a few desperate patients and a handful of physicians willing to sign letters. The previous six people in the country who had obtained a licence had all needed a court ruling to force the Ministry's hand.

Gil spent four years on the paperwork instead. In 2004, his direct application to the Ministry of Health was approved. No judge. No court order. He became Patient #7 — and the administrative pathway he opened became the route every Israeli patient has taken since.

The medicine worked. But patients were being handed flowers and oils with no dose, no titration, no guidance — and then being blamed when it didn't work. That wasn't medicine. That was abandonment with a prescription pad.

In 2005, he founded the Israel Medical Cannabis Association — the country's first structured patient advocacy and education body. In 2008, the Ministry of Health licensed him as Israel's first Medical Cannabis Instructor. That same year he built Israel's first formal patient education programme. In 2012, the first nurses' education programme. The clinical onboarding system he developed was adopted by Tikun Olam, BOL Pharma, Shibolet, and IMC — and moved average patient retention from four months to thirty-four.

He has personally supervised more than 10,000 patients. More than 100,000 have been onboarded through the system he built. He has advised the governments of Israel, the Czech Republic, and Bulgaria; addressed the Czech Parliament in 2012; and holds a US patent (US11346051B2) for cold terpene-printing technology. He studied at Ben Gurion University and, later, at Shenkar College of Engineering and Design — through chemotherapy.

He does this work because he knows exactly what it feels like to be the patient nobody could help.

A twenty-five year record of firsts — not claims, facts.

1999

Crohn's crisis during military service

37 kg lost in three months. Conventional treatment exhausted. Medical cannabis halts the decline and begins a four-year fight for a licence.

2004 · Patient #7

First direct Ministry of Health licence without a court order

The six prior Israeli medical cannabis patients had all required judicial intervention. Gil's application was granted by administrative pathway — changing the route for every patient since.

2005

Founded the Israel Medical Cannabis Association

The country's first national patients' organisation. Built the earliest structured advocacy and patient-education infrastructure in Israeli cannabis medicine.

2008

Licensed as Israel's first Medical Cannabis Instructor

Ministry of Health certification — not a self-declared title. In the same year, designed and launched Israel's first formal patient education programme.

2012

First nurses' education programme · Addressed the Czech Parliament

Built Israel's first clinical cannabis curriculum for nurses. Delivered testimony to the Czech Parliament that year; his input opened the Schengen zone to medical cannabis patients.

2008 — 2022

The clinical onboarding system

Implemented across Tikun Olam, BOL Pharma, Shibolet, and IMC — Israel's largest licensed operators. Moved average patient retention from 4 months to 34. 10,000+ patients personally supervised; 100,000+ onboarded through the system.

Patent · US11346051B2

Cold terpene-printing technology

US patent holder for a novel method of preserving and applying cannabis-derived terpenes at low temperature.

Government advisory

Israel · Czech Republic · Bulgaria

Direct consultation on medical cannabis patient access, regulation, and clinical frameworks — including Parliamentary testimony and cross-border patient rights.

These aren't marketing figures. They're the operating history.

434
Months of average patient retention, before and after the onboarding system — across Israel's largest licensed operators.
10,000+
Patients personally supervised by Gil under the protocol.
100,000+
Patients onboarded through the system across Israeli licensed operators.
2008
Licensed as Israel's first Ministry of Health Medical Cannabis Instructor.

Worked with, advised, or educated — operators and governments.

Operator · Israel
Tikun Olam
Operator · Israel
BOL Pharma
Operator · Israel
IMC
Operator · Israel
Shibolet
Operator · Israel
Siach
Operator · Israel
Bazelet Group
Operator · Israel
Sheifa Lachaim
Tech · Israel
Eybna Technologies
Tech · USA
YoFuMo
Government · Israel
Ministry of Health
Government · Israel
Knesset
Government · Czech Republic
Parliament
Press & Media — to be added

Two ways in — depending on who you are.

For Patients · B2C

Cannabis Rescue Session

For medical cannabis patients whose prescription isn't working. Ninety minutes with Gil. You leave with a written, personalised clinical protocol — the same day.

Duration
90 min
Fee
$250
Deliverable
Titration Map
  • Review of current prescription, dosing, and response
  • Written Titration Map delivered same day
  • Clear next steps for your physician or pharmacist
See the Rescue Session
For Operators · B2B

Business Audit Call

For medical cannabis operators losing patients inside the first 90 days. Ninety minutes with Gil. You leave with a written Retention Assessment and the intervention roadmap — the entry point to a three-phase engagement.

Duration
90 min
Fee
$500
Deliverable
Retention Assessment
  • Diagnostic of your patient onboarding and retention funnel
  • Written Retention Assessment delivered same day
  • Intervention roadmap — the gateway to a full engagement
See the Business Audit

For media enquiries, speaking invitations, or government consultations — email directly.

Gil reads and responds to his own email. For the two structured offers — Cannabis Rescue Session or Business Audit Call — booking, date, time, and payment all happen on the offer pages above, in one flow.